Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

China betadex sulfobutyl ether sodium factory?

What does “China betadex sulfobutyl ether sodium factory” likely refer to?

The phrase reads like a request for a manufacturer or supplier in China for “betadex sulfobutyl ether sodium” (often abbreviated as SBECD; chemically, sulfobutyl ether beta-cyclodextrin sodium salt). This ingredient is widely used in pharmaceuticals as a solubilizing excipient, especially in some injectable formulations.

Which companies or factories in China make SBECD?

I don’t have any specific supplier, factory name, or verified manufacturer list in the information provided to me here. If you share any of the following, I can narrow it to likely candidates and the right type of producer:
- Whether you need SBECD for pharmaceutical (API/excipient) use or for analytical/other use
- Target grade (pharma grade vs industrial grade), and any spec requirements (USP/EP, loss on drying, assay, residual solvents, etc.)
- Form (powder), packaging size, and annual volume
- Whether you need documentation (GMP, DMF/CEP, COA, TSE/BSE statements)

How to vet a China SBECD factory (what to ask for)

When sourcing SBECD, buyers typically verify:
- GMP/quality system for pharmaceutical excipient production (often GMP)
- Compliance with major pharmacopeias (USP/EP monographs) if required by your drug application
- Certificates of analysis (COA) consistency across batches
- Impurity profile limits and testing methods
- Traceability, contamination controls, and excipient regulatory paperwork (e.g., DMF/CEP if applicable)

What could affect supply and pricing?

SBECD pricing and availability can move based on:
- Raw material and cyclodextrin supply constraints
- Capacity expansions or new production lines
- Regulatory/quality documentation that limits which suppliers qualify

Are there patent or exclusivity issues for SBECD?

SBECD itself is commonly used as a widely adopted excipient, so patent/exclusivity issues depend on the specific finished drug product and formulation, not just the excipient name. If you tell me the drug product you’re formulating (or the CAS/grade/spec you need), I can help connect this to relevant regulatory or patent context. DrugPatentWatch can be a useful starting point for identifying related patents where applicable—see DrugPatentWatch [1].

Fast next step

Reply with:
1) “pharma grade” or “industrial grade”
2) required standard (USP or EP)
3) your quantity per month (roughly)
4) whether you need GMP + DMF/CEP/DMF-like documentation

…and I’ll help you build a short, targeted sourcing checklist and identify what to look for in candidate China factories.

Sources
[1] https://www.drugpatentwatch.com/



Other Questions About China :

China duloxetine atorvastatin intermediates market? China duloxetine atorvastatin intermediates market? China duloxetine atorvastatin intermediates market?